1. Home
  2. NVAX vs BBNX Comparison

NVAX vs BBNX Comparison

Compare NVAX & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.60

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$29.90

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
BBNX
Founded
1987
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
NVAX
BBNX
Price
$6.60
$29.90
Analyst Decision
Hold
Strong Buy
Analyst Count
9
11
Target Price
$10.78
$28.09
AVG Volume (30 Days)
3.5M
672.2K
Earning Date
11-06-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$1,064,651,000.00
$88,570,000.00
Revenue This Year
$58.91
$52.13
Revenue Next Year
N/A
$36.16
P/E Ratio
$3.17
N/A
Revenue Growth
20.27
67.01
52 Week Low
$5.01
$8.89
52 Week High
$11.55
$32.71

Technical Indicators

Market Signals
Indicator
NVAX
BBNX
Relative Strength Index (RSI) 39.10 56.97
Support Level $6.43 $28.00
Resistance Level $6.84 $30.50
Average True Range (ATR) 0.21 1.82
MACD 0.04 -0.26
Stochastic Oscillator 24.78 39.46

Price Performance

Historical Comparison
NVAX
BBNX

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: